Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor David Smith reflects on a research career which spans over fifty years

Professor A David Smith is an Emeritus Professor of Pharmacology at Oxford and former Head of Department. He completed a degree in Biochemistry from Christchurch College in 1963 before moving to Pharmacology to complete his DPhil under the supervision of Professor Hugh Blaschko FRS.

First presented at the Department of Pharmacology Science Day held Tuesday 3 October 2017

Similar stories

Key cellular channel identified as a brake on lung scarring

Pulmonary fibrosis is a serious and often fatal condition in which lung tissue becomes progressively scarred, stiff, and less able to transfer oxygen into the bloodstream. With limited treatment options and no cure other than lung transplantation, there is an urgent need to understand the biological mechanisms that drive this disease. A new study from the Grimm Group, published in The EMBO Journal, identifies a previously unrecognised protective role for a cellular ion channel called TRPML1 in preventing lung scarring. The research shows that when this channel is absent or non-functional, the lungs develop a fibrosis-like condition marked by excessive accumulation of structural proteins such as collagen and elastin